GovChime
Notice ID: 8a49dd25c0e646a79087bd93eaeed660Award NoticeAwarded

6550--Blood Bank Reagents 5 Year OP IDIQ - Detroit

Awarded on October 1, 2026. The description is published on SAM.gov: Full description on SAM.gov.

Awarded tounder 36C25027D0003 (source: SAM.gov award notice)• $125.0K

Overview

Posted
October 1, 2026
Notice type
Award Notice
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Veterans Affairs

Notice details

Office
250-NETWORK CONTRACT OFFICE 10 (36C250)
Place of performance
VA Medical Center 4646 John R. Street, Detroit, MI, 48201
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov
Award date
Oct 1, 2026
Award amount (SAM.gov award notice)
$125.0K

Identifiers

Solicitation number
36C25026Q0790
Notice ID
8a49dd25c0e646a79087bd93eaeed660
Award number (PIID)
36C25027D0003

Description

No description in the SAM.gov data feed for this notice.

Full description on SAM.gov

Award Overview

Award Number

36C25027D0003

Award Amount (SAM.gov award notice)

$125.0K

Award Date

Oct 1, 2026

Awardee

Awardee UEI

ZFXRG96JMJ39

Awardee CAGE Code

12B04

Awardee Address

SAN DIEGO, CA 92121, CA

Original Solicitation

Notice ID: 8a49dd25c0e646a79087bd93eaeed660

Posted Date: Oct 1, 2026

Original Response Deadline: Not specified

Task Orders Under This IDV

Top 10 by total obligated

1
  • 36C25027N0036
    QUIDELORTHO SALES COMPANY, LLC
    Department of Veterans AffairsNAICS 334516
    $21.1KSigned Oct 1, 2026

More From This Vendor

Top 5 most recent

5
  • 36C24127F0035
    QUIDELORTHO SALES COMPANY, LLC
    Department of Veterans AffairsNAICS 334516
    $96.7KSigned Nov 6, 2026
  • 36C24127F0036
    QUIDELORTHO SALES COMPANY, LLC
    Department of Veterans AffairsNAICS 334516
    $99.9KSigned Nov 6, 2026
  • 36C24127F0037
    QUIDELORTHO SALES COMPANY, LLC
    Department of Veterans AffairsNAICS 334516
    $20.2KSigned Nov 6, 2026
  • 36C24127F0038
    QUIDELORTHO SALES COMPANY, LLC
    Department of Veterans AffairsNAICS 334516
    $17.6KSigned Nov 6, 2026
  • 36C25025N0714
    QUIDELORTHO SALES COMPANY, LLC
    Department of Veterans AffairsNAICS 334516
    $9.0KSigned Nov 4, 2026

Contacts

Contracting Officer

Primary Contact

Kellie Konopinski
Contracting Officer

Documents

Files (3)

  • S02 RFQ 36C25026Q0790.pdf

    525 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download
  • 36C25027D0003_1.docx

    22 KBAdded in Award Notice version 2Posted
    Download
  • 36C25026Q0790_1.docx

    14 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Combined Synopsis/Solicitation

    6550--Blood Bank Reagents, Detroit

    Notice aee021a10aac448ba2e2bd5a43992cc5 on SAM.gov

  2. 2
    Version 2Award NoticeCurrent

    Type changed from Combined Synopsis/Solicitation to Award Notice

    6550--Blood Bank Reagents 5 Year OP IDIQ - Detroit

    Notice 8a49dd25c0e646a79087bd93eaeed660 on SAM.gov

Other notices for this solicitation

  1. AwardedRelated noticeOct 1, 2026

    6550--Blood Bank Reagents 5 Year OP IDIQ - Detroit

    Notice 765426f399ae4adb9705688d07490920 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
-AwardedOpen
Brand Name Only, Unrestricted, RFQ for Blood Bank Reagents.
-Combined Synopsis08/12/2026
Notice of Intent to Sole-Source Requirement The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The associated NAICS code for this is 334516, Size Standard is 1,000 employees. Product Service Code (PSC) is Q301. The sole-source contract will be awarded to: VERACYTE, INC UEI: JS7GBP6LCMN6 Description of equipment requirements: The VA Northeast Ohio Healthcare System (VANEOHS) requires continued access to specialized genomic classifier testing used to assess risk of metastasis or metastatic progression in patients with localized or advanced prostate cancer. Decipher prostate testing is a powerful diagnostic and prognostic tool that assesses risk of prostate cancer progression within the next five years post detection, biopsy or surgical removal. The test utilizes a genome-wide transcriptome assay to analyze the expression of 22 genes to generate the Decipher score. Performed on existing tissue samples obtained during biopsy or surgical removal of the prostate, prior to any radiation or hormone therapy. Indicated in localized, N1, or metastatic disease. Provides the Decipher score based on genomic characteristics of the tumor, independent of clinical and pathological factors. The score, ranging between 0 and 1, reflects tumor aggressiveness. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. IAW FAR 5.207 all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. This is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that demonstrates the ability to comply with the requirement and that competition would be advantageous to the Government. The Government will not pay for information submitted. A determination not to compete based on responses to this notice is solely within the discretion of the Government. All responses to this intent to sole source must be emailed to Thomas Bellamy: thomas.bellamy@va.gov & Samantha Jarrett: samantha.jarrett@va.gov by 4:00 p.m. EST November 12th, 2026.
-Special Notice11/12/2026
Notice of Intent to Sole Source Department of Veterans Affairs, VISN 10, Northern Indiana VAHCS, 1700 East 38th St., Marion, IN 46953, intends to solicit and negotiate with only one source under Simplified Acquisition Procedures and the authority of FAR Part 6.302-1, Only One Responsible Source for Reagents. The associated NAICS code for this is 334516. The vendor will be Roche Diagnostics Corp., 9115 Hague Rd., Indianapolis, IN 46256. Description of Equipment or Supplies Added to Current Contract: Product Name QTY A1C 22787 Acetaminophin 58 AFP 491 ALB 27937 ALP 27280 ALT 27493 Ammonia (NH3) 250 Amphetamines 3722 Amylase 376 Anti-HAV IgM 129 Anti-HBc 267 Anti-HBc IgM 255 Anti-HBs 753 Anti-HCV 1065 AST 27423 Barbituates 3725 Benzodiazapine 3731 Betahydroxybuterate 43 Bilirubin-Direct 4643 Bilirubin-Total 27271 BUP 671 Calcium 32551 CEA 130 Chloride 32573 Cholesterol 22106 CK 947 CO2 32565 COC 3725 Cortisol 107 Creatinine 34477 CRP 1043 CystC 1033 Dig 112 ETOH 453 FEN 3559 Ferritin 2289 FOLATE 2701 Free T3 199 Free T4 2007 FSH 174 GGT 170 Glucose 32527 HBsAg 885 HcG 60 HDL 22113 High Sensitive CRP 45 HIV 777 IGA 97 IGG 93 IGM 97 IRON 2377 Lactate 513 LDH 231 LDL - Direct 1392 LH 161 Lipase 713 Lithium 177 Magnesium 5685 Methodone 3728 Microalbumin 7850 Opiates 3725 Oxycodone 3755 PCP 3729 Phenytonin 71 Phosphate 1009 Potassium 32709 Prealbumin 35 Pro-BnP 859 Procalcitonin 293 Prolactin 188 PSA 10521 PTH 527 Rheumatoid Factor 325 Salicylates 57 Sodium 32641 T4 67 Testo 1563 THC 3729 Total Protein 27259 Triglycerides 22591 Troponin T 1215 TSH 18616 UIBC 2344 Urea Nitrogen/BUN 33051 Uric Acid 781 Urine Total Protein 501 Valproic Acid 221 Vancomyacin 31 Vit B12 3021 VIT D 18771 Northern Indiana Health Care System utilizes these tests with existing Roche Cobas Pros instruments for testing. A firm fixed price contract is anticipated and shall be awarded. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to negotiate with only this source. This notice of intent is not a request for competitive proposals. It is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Responses must be received no later than 12:00 pm on Friday, October 30, 2026. Point of contact is Rachel MacRae, e-mail rachel.macrae@va.gov.
-Special Notice10/30/2026
INTENT TO SOLE SOURCE AND JUSTIFICATION
-Special Notice08/25/2026

Additional Details

Solicitation Number

36C25026Q0790

Archive Date

Nov 30, 2026

Office Address

DAYTON, OH, 45428